It is very interesting how they think a letter will have any gravitas when considering the long term survival rate
But as we know Incyte may not be that in-sight-ful
LOL
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-385
-
- There are more pages in this discussion • 623 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.8¢ |
Change
-0.013(1.29%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $1.967M | 2.038M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 14172 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 66018 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 14172 | 0.955 |
21 | 104529 | 0.950 |
19 | 250762 | 0.945 |
18 | 289023 | 0.940 |
12 | 332620 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 66018 | 21 |
0.965 | 115275 | 18 |
0.970 | 176956 | 16 |
0.975 | 180164 | 11 |
0.980 | 218794 | 8 |
Last trade - 13.59pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online